Abstract
PURPOSE: Concerns for infections resulting from antineoplastic therapy-associated immunosuppression may deter referral for symptom palliation with a tunneled pleural catheter (TPC) in patients with malignant/para-malignant pleural effusions (MPE/PMPE). While rates of TPC-related infections range from 1 to 21%, those in patients receiving antineoplastic therapy with correlation to immune status has not been established. We aimed to assess TPC-related infection rates in patients on antineoplastic therapy, determine relation to immune system competency, and assess impact on the patient.
METHODS: Patients with a MPE/PMPE undergoing TPC management associated with antineoplastic therapy, from 2008 to 2016, were reviewed and categorized into those with an immunocompromised versus immunocompetent immune status.
RESULTS: Of the 150 patients, a TPC-related infection developed in 13 (9%): pleural space in 11 (7%) and superficial in 2 (1%). Ninety-three percent (139/150) were identified to be immunocompromised during their antineoplastic therapy. No difference in TPC-related infections was seen in patients with an immunocompromised (9%, 12/139) versus immunocompetent status (9%, 1/11); p = 0.614. The presence of a catheter-related infection did not negatively impact overall survival over a median follow-up of 144 days (interquartile range 41-341); p = 0.740.
CONCLUSIONS: These results suggest that antineoplastic therapy may not significantly increase the overall risk of TPC-related infections, as the rate remains low and comparable to rates in patients not undergoing antineoplastic therapy. Regardless of immune status, the presence of a catheter-related infection did not negatively impact overall survival. These results should reassure clinicians that the need to initiate antineoplastic therapy should not delay definitive pleural palliation with a TPC.
| Original language | American English |
|---|---|
| Pages (from-to) | 1525-1531 |
| Number of pages | 7 |
| Journal | Supportive Care in Cancer |
| Volume | 26 |
| Issue number | 5 |
| DOIs | |
| State | Published - Nov 29 2017 |
Keywords
- Aged
- Catheter-Related Infections/etiology
- Catheters, Indwelling/adverse effects
- Drainage/adverse effects
- Female
- Humans
- Immunocompromised Host
- Male
- Middle Aged
- Neoplasms/immunology
- Palliative Care
- Pleural Effusion, Malignant/immunology
- Pleurodesis/adverse effects
- Retrospective Studies
- Treatment Outcome
Disciplines
- Surgery
- Critical Care
- Medicine and Health Sciences
Fingerprint
Dive into the research topics of 'Tunneled pleural catheter use for pleural palliation does not increase infection rate in patients with treatment-related immunosuppression'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver